Lv4
602 积分 2024-09-12 加入
SMARCA4-deficient NSCLC treated with first-line tislelizumab and fruquintinib achieved remarkable tumor regression: case report and literature review
12天前
已完结
SMARCA4-deficient non-small cell lung cancer with metastasis to the sigmoid colon: a case report
12天前
已关闭
Pathogenomics for accurate diagnosis, treatment, prognosis of oncology: a cutting edge overview
12天前
已完结
Ceritinib efficacy in SMARCA4-deficient NSCLC harboring novel CTNND2 ALK/EML4-ALK fusion: case report
13天前
已关闭
Successful treatment with sintilimab plus anlotinib for SMARCA4-deficient non-small cell lung cancer withMET exon 14 skipping: a case report
13天前
已关闭
Successful treatment with sintilimab for SMARCA4-deficient non-small cell lung carcinoma: two case reports
13天前
已完结
Case Report: Ensartinib as a first-line treatment for SMARCA4-deficient and EML4-ALK non-small cell lung cancer
13天前
已完结
SMARCA4 Deficiency in Lung Cancer: From Signaling Pathway to Potential Therapeutic Targets
13天前
已完结
SMARCA4缺失性非小细胞肺癌新辅助治疗后病理学疗效评价及预后分析
13天前
已完结
Promising efficacy of immune checkpoint inhibitor plus chemotherapy for thoracic SMARCA4-deficient undifferentiated tumor
14天前
已完结
皖公网安备34019202002308
